Right heart catheterization is the gold standard for the assessment of pulmonary hypertension. It is critical at different steps in the differential diagnosis and the distinction between post and pre-capillary Pulmonary Hypertension. It also provides insights on outcome and is an important guide for treatment decisions in pulmonary vascular diseases (PAH and CTEPH) and in advanced heart failure (MCS and HTX). Although widely used in clinical practice, right heart catheterization requires specific knowledge both in data collection and interpretation of results. This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.
Ioana Preston, MD, and Jaime Hernandez-Montfort, MD
Absolute Beginners: Right Heart Catheterization in Pre-capillary Pulmonary Hypertension
Colin Church, BSC(Hons), PhD, FRCP, Golden Jubilee National Hospital, Glasgow, UK
This talk will cover the importance of RHC in the evaluation of pre-capillary PH and discuss how invasive HD is integrated in the assessment of severity in PAH/CTEPH
A Town Called Malice: What is the Wedge? Invasive Hemodynamics in Advanced Heart Failure
Ryan Tedford, MD, Medical University of South Carolina (MUSC), Charleston, SC, USA
The distinction between pre and post capillary PH is based on PAWP, a single pressure measurement. As simple as it seems, this measurement may be difficult to record (when, how). This talk will discuss technical issues, what are the normal values and how to interpret PAWP in patients with heart failure.
Going Underground: Can This Patient Be Weaned From LVAD?
Emma Birks, MD, University of Kentucky, Lexington, KY, USA
There is growing evidence that patients implanted with a LVAD may safely be weaned from the device. Although no specific protocol has been accepted, many centers use RHC at rest or during exercise for decision-making purposes. This talk will cover the role of RHC in identifying patients in whom weaning may be considered.
That’s Entertainment: Testing Vasoreactivity in Pulmonary Hypertension
Celine Dewachter, MD, PhD, Erasme Hospital, Brussels, Belgium
Pulmonary hypertension is a hemodynamic condition. In some specific clinical situations, PH may be reversed even in the presence of disturbed hemodynamics. This talk will discuss the role of vasoreactivity testing in PAH, left heart disease and MCS/heart transplantation.
Live Q&A with All Speakers
Led by Moderators
Greg Schultz, ISHLT CEO